Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedDec 15, 2025
DataAggregated Company Financials
Companies7799
  • 7D-0.6%
  • 3M2.5%
  • 1Y12.4%
  • YTD16.0%

The market has been flat over the last week. As for the longer term, the market has risen 12% in the past 12 months. Earnings are forecast to grow by 16% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 15 Dec 2025US$71.8tUS$23.1tUS$2.3t19.1x31.4x3.1x
Wed, 12 Nov 2025US$71.6tUS$23.1tUS$2.3t18.3x31.6x3.1x
Fri, 10 Oct 2025US$71.6tUS$22.9tUS$2.2t18.9x32.7x3.1x
Sun, 07 Sep 2025US$68.3tUS$22.9tUS$2.2t19.1x31.3x3x
Tue, 05 Aug 2025US$65.2tUS$22.7tUS$2.1t18.3x30.6x2.9x
Thu, 03 Jul 2025US$64.6tUS$22.5tUS$2.1t18.6x30.8x2.9x
Sat, 31 May 2025US$61.5tUS$22.4tUS$2.1t17.8x29.3x2.7x
Mon, 28 Apr 2025US$57.3tUS$22.0tUS$2.1t16.9x27.2x2.6x
Wed, 26 Mar 2025US$60.3tUS$21.9tUS$2.0t17.7x29.4x2.7x
Fri, 21 Feb 2025US$64.8tUS$21.9tUS$2.1t18.3x31.6x3x
Sun, 19 Jan 2025US$63.2tUS$22.0tUS$2.0t18.9x32.2x2.9x
Tue, 17 Dec 2024US$63.8tUS$22.0tUS$1.9t19x33x2.9x
Thu, 14 Nov 2024US$63.0tUS$22.0tUS$1.9t19x33x2.9x
Sat, 12 Oct 2024US$59.9tUS$21.6tUS$1.9t18.4x32.1x2.8x
Mon, 09 Sep 2024US$55.7tUS$21.5tUS$1.9t17.5x29.9x2.6x
Wed, 07 Aug 2024US$53.9tUS$21.5tUS$1.9t17.1x28.9x2.5x
Fri, 05 Jul 2024US$57.3tUS$21.3tUS$1.8t16.8x31.2x2.7x
Sun, 02 Jun 2024US$54.6tUS$21.3tUS$1.8t17.3x29.9x2.6x
Tue, 30 Apr 2024US$53.1tUS$21.2tUS$1.8t16.7x28.8x2.5x
Thu, 28 Mar 2024US$54.6tUS$21.1tUS$1.8t17.1x29.6x2.6x
Sat, 24 Feb 2024US$52.9tUS$21.0tUS$1.8t16.5x29.5x2.5x
Mon, 22 Jan 2024US$50.5tUS$21.0tUS$1.7t16.6x29x2.4x
Wed, 20 Dec 2023US$50.2tUS$21.0tUS$1.8t16.8x28.6x2.4x
Fri, 17 Nov 2023US$47.1tUS$21.0tUS$1.7t15.8x27.1x2.2x
Sun, 15 Oct 2023US$45.4tUS$21.0tUS$1.7t15.1x26.3x2.2x
Tue, 12 Sep 2023US$47.2tUS$20.9tUS$1.7t15.6x27.5x2.3x
Thu, 10 Aug 2023US$47.5tUS$20.9tUS$1.7t16x28x2.3x
Sat, 08 Jul 2023US$46.5tUS$20.9tUS$1.7t15.4x28x2.2x
Mon, 05 Jun 2023US$45.3tUS$21.0tUS$1.7t14.8x27.2x2.2x
Wed, 03 May 2023US$43.1tUS$20.9tUS$1.7t14.6x26.1x2.1x
Fri, 31 Mar 2023US$42.9tUS$20.6tUS$1.6t14.9x26.5x2.1x
Sun, 26 Feb 2023US$42.4tUS$20.5tUS$1.7t15.2x25.7x2.1x
Tue, 24 Jan 2023US$43.2tUS$20.5tUS$1.8t14.9x24.2x2.1x
Thu, 22 Dec 2022US$41.3tUS$20.5tUS$1.8t14.3x22.9x2x
Price to Earnings Ratio

22.9x


Total Market Cap: US$41.3tTotal Earnings: US$1.8tTotal Revenue: US$20.5tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 29.1x202320242025
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading at a PE ratio close to its 3-year average PE ratio of 29.1x.
Past Earnings Growth
  • The earnings for American listed companies have grown 8.2% per year over the last three years.
  • Revenues for these companies have grown 4.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market-0.59%
Materials2.54%
Financials2.21%
Industrials1.04%
Consumer Staples0.87%
Healthcare0.43%
Consumer Discretionary0.25%
Real Estate-0.74%
Utilities-1.16%
Energy-1.32%
Tech-2.39%
Telecom-2.94%
Sector PE
  • Investors favour the Healthcare sector the most for future growth even though it's trading below its 3-year average PE ratio of 65.0x.
    • Analysts expect its future annual earnings growth (17.1%) to be largely in line with prior year's earnings growth.
    • The market's confidence could indicate that the market believes that analysts are underestimating future growth.
  • The Energy sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 12.5x.
Forecasted Growth
  • Analysts are most optimistic on the Consumer Discretionary sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings growth rate of 0.01% per year.
  • In contrast, the Utilities sector is expected to see its earnings grow by 9.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
V VisaUS$347.836.4%
+US$40.1b		10.1%PE33.5xFinancials
MA MastercardUS$571.935.8%
+US$28.3b		7.8%PE36xFinancials
LLY Eli LillyUS$1.03k3.0%
+US$26.8b		31.9%PE50xHealthcare
WMT WalmartUS$116.702.8%
+US$25.0b		23.0%PE40.6xConsumer Staples
JNJ Johnson & JohnsonUS$211.584.9%
+US$24.0b		47.1%PE20.3xHealthcare
See more

Market Insights

Header cover image
🤖 AI Companies Hit The Bond Market
Richard Bowman avatar
Richard Bowman
|
|
The recent dip in stock prices came on the back of stretched valuations and fears of an AI fueled bubble. This time the nervousness also spilled into the corporate bond market...
Continue reading
Three Reasons Why REITs Could Rally in 2026 🏘️
Last Week

Three Reasons Why REITs Could Rally in 2026 🏘️

Latest News

V
US$347.83
Visa
7D
6.4%
1Y
10.1%
ORCL
US$189.97
Oracle
7D
-13.9%
1Y
10.9%

ORCL: AI Infrastructure Commitments Will Drive Multi-Year Cloud Demand Upside

The analyst fair value estimate for Oracle has been raised from $325.00 to $400.00 per share as analysts balance accelerating AI driven revenue growth, supported by robust RPO and bullish buy rated initiations and target hikes, against near term margin pressure, heavier capex, and mixed views on the sustainability and quality of large cloud commitments. Analyst Commentary Street research remains divided on Oracle, but recent commentary has tilted toward a constructive outlook as investors digest record AI related backlog, ambitious FY30 targets, and evolving profitability expectations.
UBER
US$85.11
Uber Technologies
7D
-8.1%
1Y
41.3%

UBER: Autonomous Expansion Will Sustain Platform Engagement And Profit Momentum

Analysts have modestly raised their fair value estimate for Uber Technologies by about $1 per share to roughly $112, citing a strong Q3 print, accelerating delivery growth versus peers, and confidence that robust engagement and profit expansion can continue even as margin gains normalize and long term autonomous vehicle economics become a greater focus. Analyst Commentary Analysts remain broadly constructive on Uber following the Q3 update, pointing to solid execution across mobility and delivery, resilient user engagement, and a strengthening narrative around long term autonomous vehicle positioning, even as expectations for near term AV profit contribution are tempered.
LLY
US$1,027.51
Eli Lilly
7D
3.0%
1Y
31.9%

LLY: Government Access Deals Will Drive Durable Obesity And Diabetes Leadership

Analysts have raised their fair value estimate for Eli Lilly shares from approximately $1,170 to about $1,430 per share, reflecting higher expected profitability and sustained leadership in the GLP 1 obesity and diabetes market, supported by recent U.S. government access deals and upcoming launches such as orforglipron. Analyst Commentary Bullish analysts continue to frame Eli Lilly as a core beneficiary of the expanding obesity and diabetes treatment market, with valuation upside tied to both higher GLP 1 penetration and a broadening metabolic pipeline.
NVDA
US$175.02
NVIDIA
7D
-5.7%
1Y
32.6%

NVDA: AI Data Center Demand May Sustain Leadership Amid Rising Geopolitical And Competition Risks

Analysts modestly lift their fair value estimate for Nvidia to about $175 per share from roughly $152, citing a sustained build out of AI data center infrastructure, stronger long term revenue growth expectations, and premium AI leadership, partially offset by rising competitive and execution risks. Analyst Commentary Street research remains broadly constructive on Nvidia, with most firms highlighting the company as the central beneficiary of a multi year AI infrastructure build.
GEV
US$671.71
GE Vernova
7D
8.0%
1Y
98.9%

GEV: Dividend Hike And Buybacks Will Drive Stronger Shareholder Returns

Analysts have raised their price target for GE Vernova from approximately $760.00 to about $927.34 per share, reflecting increased confidence in the company’s accelerating revenue growth, improving profit margins, and slightly higher justified valuation multiples. What's in the News Reaffirmed 2025 revenue guidance of $36 billion to $37 billion and introduced 2026 guidance of $41 billion to $42 billion, underscoring confidence in multi year growth visibility (Corporate guidance).
JNJ
US$211.58
Johnson & Johnson
7D
4.9%
1Y
47.1%
AVGO
US$359.93
Broadcom
7D
-10.3%
1Y
44.0%

A tech powerhouse quietly powering the world’s AI infrastructure.

Broadcom's Q4 Results: The Beat and Drop Market Update: Broadcom (AVGO) Q4 Fiscal 2025 Results Date of Report: December 11, 2025 Below is an analysis of Broadcom’s latest financial results, the subsequent valuation impact, and the specific reasons behind the market's negative reaction. 1.
AMD
US$210.78
Advanced Micro Devices
7D
-4.7%
1Y
66.4%
MA
US$571.93
Mastercard
7D
5.8%
1Y
7.8%
MSFT
US$478.53
Microsoft
7D
-1.0%
1Y
7.0%
META
US$644.23
Meta Platforms
7D
-3.4%
1Y
3.2%

META: AI Spending And Regulatory Pressures Will Shape Balanced Return Prospects

Analysts have raised their fair value estimate for Meta Platforms to approximately $693 per share from about $605, citing stronger AI driven revenue growth and durable ad share gains that more than offset near term margin pressure from elevated infrastructure and capex investment. Analyst Commentary Street research remains broadly constructive on Meta, but the recent earnings cycle has sharpened debate around how much of the company’s artificial intelligence upside is already reflected in the share price.
GOOGL
US$309.29
Alphabet
7D
-1.4%
1Y
57.3%
WMT
US$116.70
Walmart
7D
2.8%
1Y
23.0%
UNH
US$341.84
UnitedHealth Group
7D
5.6%
1Y
-31.4%

UNH: Medicare Star Ratings Will Drive Multi-Year Margin Recovery Ahead

UnitedHealth Group's updated fair value estimate has inched up by about $1.80 to roughly $388.50, as analysts factor in modestly faster long term earnings growth, sector wide Medicare Advantage and Medicaid margin recovery, and improving visibility into multi year margin expansion at Optum. Analyst Commentary Bullish analysts are largely focused on UnitedHealth's improved earnings visibility and margin recovery trajectory, which supports the modest increase in fair value.
AXP
US$382.56
American Express
7D
5.6%
1Y
26.0%

AXP: Future Results Will Reflect Execution Strength Amid Mixed Market Sentiment

American Express's analyst price target has been modestly increased by $1 to $351.87. Analysts cite stronger-than-expected revenue expansion, higher profit margins, and improved growth trends, supported by recent upgrades and positive financial results.